Showing results (1-10 of 148) with videos related to
Sort By:
Pageof 15
Seminars in Thrombosis and Hemostasis|October 10, 2015
Targeting factor replacement therapy in severe hemophilia: which level is important?Kathelijn Fischer, Erik BerntorpBlood Cells, Molecules & Diseases|March 18, 2017
Primary prophylaxis in haemophilia care: Guideline update 2016Kathelijn Fischer, Rolf LjungBlood Transfusion = Trasfusione Del Sangue|June 13, 2014
Quality of haemophilia care in The Netherlands: new standards for optimal careFrank W G Leebeek, Kathelijn FischerBritish Journal of Haematology|April 8, 2017
Large scale studies assessing anti-factor VIII antibody development in previously untreated haemophilia A: what has been learned, what to believe and how to learn moreAlfonso Iorio, Kathelijn Fischer, Michael MakrisHaemophilia : the Official Journal of the World Federation of Hemophilia|June 26, 2012
Models of prophylaxisErik Berntorp, Kathelijn Fischer, Alec MinersSeminars in Thrombosis and Hemostasis|March 18, 2003
Prophylaxis for severe hemophilia: experience from Europe and the United StatesH Marijke van den Berg, Kathelijn FischerInternational Urogynecology Journal|March 23, 2012
Health-related quality of life. The effect of pelvic floor muscle training and midurethral sling surgery: a systematic reviewJulien Labrie, Kathelijn Fischer, C Huub van der VaartBlood Transfusion = Trasfusione Del Sangue|December 19, 2012
Outcome in moderate haemophiliaIngrid den Uijl, Douwe Biesma, Diederick Grobbee, et al.Blood Transfusion = Trasfusione Del Sangue|November 15, 2012
Turning severe into moderate haemophilia by prophylaxis: are we reaching our goal?Ingrid den Uijl, Douwe Biesma, Diederick Grobbee, et al.Research and Practice in Thrombosis and Haemostasis|March 18, 2024
Arthropathy on X-rays in 363 persons with hemophilia: long-term development, and impact of birth cohort and inhibitor statusDayna A M van Heel, Wouter Foppen, Kathelijn FischerPageof 15